12. Drug Repositioning Efforts by Nonprofit Foundations

  1. Michael J. Barratt5 and
  2. Donald E. Frail6
  1. Donald E. Frail6,
  2. Louis Degennaro1,
  3. Aaron Schimmer2,
  4. James Kasper1,
  5. Richard Winneker1,
  6. Todd B. Sherer3,
  7. Alison Urkowitz3,
  8. Kuldip D. Dave3,
  9. Jill Panetta4 and
  10. John McCall4

Published Online: 8 APR 2012

DOI: 10.1002/9781118274408.ch12

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

How to Cite

Frail, D. E., Degennaro, L., Schimmer, A., Kasper, J., Winneker, R., Sherer, T. B., Urkowitz, A., Dave, K. D., Panetta, J. and McCall, J. (2012) Drug Repositioning Efforts by Nonprofit Foundations, in Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs (eds M. J. Barratt and D. E. Frail), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118274408.ch12

Editor Information

  1. 5

    Washington University School of Medicine, St. Louis, Missouri, USA

  2. 6

    AstraZeneca Pharmaceuticals, Waltham, Massachusetts, USA

Author Information

  1. 1

    The Leukemia & Lymphoma Society, White Plains, New York, USA

  2. 2

    Ontario Cancer Institute, Toronto, Ontario, Canada

  3. 3

    Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA

  4. 4

    Polycystic Kidney Disease Foundation, Kansas City, Missouri, USA

  5. 6

    AstraZeneca Pharmaceuticals, Waltham, Massachusetts, USA

Publication History

  1. Published Online: 8 APR 2012
  2. Published Print: 25 MAY 2012

ISBN Information

Print ISBN: 9780470878279

Online ISBN: 9781118274408

SEARCH

Keywords:

  • nonprofit foundations, drug repositioning efforts;
  • LLS, Michael J. Fox, and PKD Foundations;
  • repositioning drugs for PD, PKD, hematological malignancies

Summary

This chapter contains sections titled:

  • Introduction

  • Repositioning of Drugs for Hematological Malignancies: Perspective from the Leukemia & Lymphoma Society

  • Repositioning Drugs for Parkinson's Disease: Perspective from the Michael J. Fox Foundation

  • Repositioning Drugs for Polycystic Kidney Disease: Perspectives from the Polycystic Kidney Disease Foundation

  • References